Foreword from the Supplement Editors

GEMMA FIGTREE, LOUISE BURRELL

Figures

Abstract

Cardiometabolic challenges

Article Extract

New developments in metabolic syndrome and diabetes are particularly impactful regarding cardiovascular complications and are hugely relevant to the burden of disease faced in primary care. The advent of sodium-glucose cotransporter-2 inhibitors is providing us with an enhanced toolkit. These agents can not only improve glycaemic control, but also have benefits on hard cardiovascular endpoints.